nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—CYP2C8—Spironolactone—dilated cardiomyopathy	0.307	0.531	CbGbCtD
Rosiglitazone—ALB—Furosemide—dilated cardiomyopathy	0.271	0.469	CbGbCtD
Rosiglitazone—CYP2C9—cardial valve—dilated cardiomyopathy	0.046	0.392	CbGeAlD
Rosiglitazone—Blood cholesterol increased—Furosemide—dilated cardiomyopathy	0.0171	0.0649	CcSEcCtD
Rosiglitazone—ACSL4—cardiac ventricle—dilated cardiomyopathy	0.0147	0.125	CbGeAlD
Rosiglitazone—ACSL4—myocardium—dilated cardiomyopathy	0.0138	0.118	CbGeAlD
Rosiglitazone—Mepyramine—SLC22A5—dilated cardiomyopathy	0.0109	1	CrCbGaD
Rosiglitazone—Blood triglycerides increased—Furosemide—dilated cardiomyopathy	0.0105	0.0399	CcSEcCtD
Rosiglitazone—ACSL4—heart—dilated cardiomyopathy	0.00964	0.0823	CbGeAlD
Rosiglitazone—ACSL4—cardiac atrium—dilated cardiomyopathy	0.00825	0.0704	CbGeAlD
Rosiglitazone—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.00719	0.0272	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00704	0.0267	CcSEcCtD
Rosiglitazone—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.00676	0.0256	CcSEcCtD
Rosiglitazone—PPARG—myocardium—dilated cardiomyopathy	0.00622	0.053	CbGeAlD
Rosiglitazone—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00603	0.0228	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00576	0.0218	CcSEcCtD
Rosiglitazone—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00497	0.0188	CcSEcCtD
Rosiglitazone—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00492	0.0186	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00461	0.0175	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00453	0.0172	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00443	0.0168	CcSEcCtD
Rosiglitazone—PPARG—heart—dilated cardiomyopathy	0.00434	0.037	CbGeAlD
Rosiglitazone—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00432	0.0164	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.0043	0.0163	CcSEcCtD
Rosiglitazone—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00418	0.0159	CcSEcCtD
Rosiglitazone—ALB—heart—dilated cardiomyopathy	0.00407	0.0347	CbGeAlD
Rosiglitazone—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00391	0.0148	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00391	0.0148	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00385	0.0146	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00384	0.0145	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00383	0.0145	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00365	0.0138	CcSEcCtD
Rosiglitazone—Urticaria—Spironolactone—dilated cardiomyopathy	0.0036	0.0136	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00336	0.0127	CcSEcCtD
Rosiglitazone—PTGS1—myocardium—dilated cardiomyopathy	0.00332	0.0284	CbGeAlD
Rosiglitazone—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00328	0.0124	CcSEcCtD
Rosiglitazone—Eye disorder—Furosemide—dilated cardiomyopathy	0.00324	0.0123	CcSEcCtD
Rosiglitazone—Pruritus—Spironolactone—dilated cardiomyopathy	0.0032	0.0121	CcSEcCtD
Rosiglitazone—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00313	0.0119	CcSEcCtD
Rosiglitazone—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.0031	0.0117	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00302	0.0114	CcSEcCtD
Rosiglitazone—Malnutrition—Furosemide—dilated cardiomyopathy	0.00302	0.0114	CcSEcCtD
Rosiglitazone—Dizziness—Spironolactone—dilated cardiomyopathy	0.00299	0.0113	CcSEcCtD
Rosiglitazone—Weight increased—Lisinopril—dilated cardiomyopathy	0.00296	0.0112	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00293	0.0111	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00287	0.0109	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00286	0.0108	CcSEcCtD
Rosiglitazone—Rash—Spironolactone—dilated cardiomyopathy	0.00285	0.0108	CcSEcCtD
Rosiglitazone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00285	0.0108	CcSEcCtD
Rosiglitazone—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00284	0.0108	CcSEcCtD
Rosiglitazone—Headache—Spironolactone—dilated cardiomyopathy	0.00284	0.0107	CcSEcCtD
Rosiglitazone—Anaemia—Furosemide—dilated cardiomyopathy	0.00279	0.0106	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00274	0.0104	CcSEcCtD
Rosiglitazone—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00272	0.0103	CcSEcCtD
Rosiglitazone—Leukopenia—Furosemide—dilated cardiomyopathy	0.0027	0.0102	CcSEcCtD
Rosiglitazone—Nausea—Spironolactone—dilated cardiomyopathy	0.00269	0.0102	CcSEcCtD
Rosiglitazone—Hepatitis—Lisinopril—dilated cardiomyopathy	0.0026	0.00986	CcSEcCtD
Rosiglitazone—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00256	0.00971	CcSEcCtD
Rosiglitazone—CYP2C9—heart—dilated cardiomyopathy	0.00254	0.0217	CbGeAlD
Rosiglitazone—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00246	0.00933	CcSEcCtD
Rosiglitazone—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00246	0.00932	CcSEcCtD
Rosiglitazone—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00242	0.00915	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00241	0.00914	CcSEcCtD
Rosiglitazone—PTGS1—heart—dilated cardiomyopathy	0.00232	0.0198	CbGeAlD
Rosiglitazone—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00226	0.00858	CcSEcCtD
Rosiglitazone—Back pain—Lisinopril—dilated cardiomyopathy	0.00219	0.0083	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00213	0.00806	CcSEcCtD
Rosiglitazone—Fatigue—Furosemide—dilated cardiomyopathy	0.00212	0.00805	CcSEcCtD
Rosiglitazone—Constipation—Furosemide—dilated cardiomyopathy	0.00211	0.00798	CcSEcCtD
Rosiglitazone—Anaemia—Lisinopril—dilated cardiomyopathy	0.00209	0.00793	CcSEcCtD
Rosiglitazone—Angioedema—Lisinopril—dilated cardiomyopathy	0.00207	0.00784	CcSEcCtD
Rosiglitazone—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00203	0.00768	CcSEcCtD
Rosiglitazone—PTGS1—cardiac atrium—dilated cardiomyopathy	0.00198	0.0169	CbGeAlD
Rosiglitazone—ACSL4—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.00197	0.0648	CbGpPWpGaD
Rosiglitazone—Urticaria—Furosemide—dilated cardiomyopathy	0.00196	0.00741	CcSEcCtD
Rosiglitazone—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00193	0.0073	CcSEcCtD
Rosiglitazone—Myalgia—Lisinopril—dilated cardiomyopathy	0.00193	0.0073	CcSEcCtD
Rosiglitazone—Oedema—Lisinopril—dilated cardiomyopathy	0.00185	0.007	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00185	0.007	CcSEcCtD
Rosiglitazone—Infection—Lisinopril—dilated cardiomyopathy	0.00184	0.00696	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00181	0.00686	CcSEcCtD
Rosiglitazone—Asthenia—Furosemide—dilated cardiomyopathy	0.00177	0.0067	CcSEcCtD
Rosiglitazone—Pruritus—Furosemide—dilated cardiomyopathy	0.00174	0.0066	CcSEcCtD
Rosiglitazone—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00169	0.00639	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00168	0.00638	CcSEcCtD
Rosiglitazone—Dizziness—Furosemide—dilated cardiomyopathy	0.00163	0.00617	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.0016	0.00605	CcSEcCtD
Rosiglitazone—Fatigue—Lisinopril—dilated cardiomyopathy	0.00159	0.00604	CcSEcCtD
Rosiglitazone—Constipation—Lisinopril—dilated cardiomyopathy	0.00158	0.00599	CcSEcCtD
Rosiglitazone—Rash—Furosemide—dilated cardiomyopathy	0.00155	0.00588	CcSEcCtD
Rosiglitazone—Dermatitis—Furosemide—dilated cardiomyopathy	0.00155	0.00588	CcSEcCtD
Rosiglitazone—Headache—Furosemide—dilated cardiomyopathy	0.00154	0.00585	CcSEcCtD
Rosiglitazone—Urticaria—Lisinopril—dilated cardiomyopathy	0.00147	0.00556	CcSEcCtD
Rosiglitazone—Nausea—Furosemide—dilated cardiomyopathy	0.00146	0.00554	CcSEcCtD
Rosiglitazone—Asthenia—Lisinopril—dilated cardiomyopathy	0.00133	0.00502	CcSEcCtD
Rosiglitazone—Pruritus—Lisinopril—dilated cardiomyopathy	0.00131	0.00495	CcSEcCtD
Rosiglitazone—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00126	0.00479	CcSEcCtD
Rosiglitazone—Dizziness—Lisinopril—dilated cardiomyopathy	0.00122	0.00463	CcSEcCtD
Rosiglitazone—Rash—Lisinopril—dilated cardiomyopathy	0.00117	0.00442	CcSEcCtD
Rosiglitazone—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00116	0.00441	CcSEcCtD
Rosiglitazone—Headache—Lisinopril—dilated cardiomyopathy	0.00116	0.00439	CcSEcCtD
Rosiglitazone—PPARG—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.00115	0.0378	CbGpPWpGaD
Rosiglitazone—Nausea—Lisinopril—dilated cardiomyopathy	0.0011	0.00416	CcSEcCtD
Rosiglitazone—PPARG—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.000897	0.0295	CbGpPWpGaD
Rosiglitazone—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.000878	0.0289	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000785	0.0258	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000738	0.0243	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.000731	0.024	CbGpPWpGaD
Rosiglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RPS6KB1—dilated cardiomyopathy	0.000667	0.0219	CbGpPWpGaD
Rosiglitazone—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.000605	0.0199	CbGpPWpGaD
Rosiglitazone—PPARG—Noncanonical Wnt signaling pathway—RAC1—dilated cardiomyopathy	0.00051	0.0168	CbGpPWpGaD
Rosiglitazone—PPARG—Wnt Signaling Pathway Netpath—GJA1—dilated cardiomyopathy	0.000454	0.0149	CbGpPWpGaD
Rosiglitazone—ACSL4—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000443	0.0146	CbGpPWpGaD
Rosiglitazone—ACSL4—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000399	0.0131	CbGpPWpGaD
Rosiglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.000378	0.0124	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.000371	0.0122	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000356	0.0117	CbGpPWpGaD
Rosiglitazone—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000355	0.0117	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.000353	0.0116	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000349	0.0115	CbGpPWpGaD
Rosiglitazone—PPARG—Wnt Signaling Pathway Netpath—RAC1—dilated cardiomyopathy	0.000346	0.0114	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—TAZ—dilated cardiomyopathy	0.000329	0.0108	CbGpPWpGaD
Rosiglitazone—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000326	0.0107	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.000322	0.0106	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.000306	0.0101	CbGpPWpGaD
Rosiglitazone—PPARG—Transcription factor regulation in adipogenesis—TNF—dilated cardiomyopathy	0.000298	0.00981	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—SDHA—dilated cardiomyopathy	0.000297	0.00977	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—LMNA—dilated cardiomyopathy	0.00029	0.00955	CbGpPWpGaD
Rosiglitazone—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000276	0.00909	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.000273	0.00899	CbGpPWpGaD
Rosiglitazone—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000273	0.00897	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00027	0.00887	CbGpPWpGaD
Rosiglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—CD36—dilated cardiomyopathy	0.000268	0.00883	CbGpPWpGaD
Rosiglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	0.000261	0.00858	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.00026	0.00857	CbGpPWpGaD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000246	0.00809	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000241	0.00792	CbGpPWpGaD
Rosiglitazone—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.000235	0.00773	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000226	0.00745	CbGpPWpGaD
Rosiglitazone—PPARG—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000202	0.00663	CbGpPWpGaD
Rosiglitazone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.0002	0.00657	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000199	0.00653	CbGpPWpGaD
Rosiglitazone—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000197	0.00649	CbGpPWpGaD
Rosiglitazone—PPARG—Regulation of retinoblastoma protein—RAF1—dilated cardiomyopathy	0.00019	0.00624	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00019	0.00624	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000182	0.00598	CbGpPWpGaD
Rosiglitazone—PPARG—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000182	0.00597	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000181	0.00596	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.000181	0.00594	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000178	0.00586	CbGpPWpGaD
Rosiglitazone—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000178	0.00585	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000177	0.00581	CbGpPWpGaD
Rosiglitazone—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000176	0.00579	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000173	0.0057	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—FAS—dilated cardiomyopathy	0.00017	0.00558	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000169	0.00555	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000165	0.00541	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000159	0.00523	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—AGT—dilated cardiomyopathy	0.000159	0.00523	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000159	0.00522	CbGpPWpGaD
Rosiglitazone—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000157	0.00517	CbGpPWpGaD
Rosiglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	0.000155	0.00509	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.000147	0.00483	CbGpPWpGaD
Rosiglitazone—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000143	0.00471	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000143	0.00469	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000141	0.00462	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.00014	0.00461	CbGpPWpGaD
Rosiglitazone—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000136	0.00447	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000128	0.00423	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000128	0.00419	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000125	0.00411	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000125	0.00411	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000125	0.0041	CbGpPWpGaD
Rosiglitazone—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000122	0.00403	CbGpPWpGaD
Rosiglitazone—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000122	0.00403	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000121	0.00399	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00012	0.00394	CbGpPWpGaD
Rosiglitazone—PPARG—Signaling events mediated by HDAC Class I—TNF—dilated cardiomyopathy	0.000118	0.00389	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	0.000117	0.00385	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000117	0.00384	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000116	0.00382	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000114	0.00374	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000112	0.00367	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000111	0.00366	CbGpPWpGaD
Rosiglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—dilated cardiomyopathy	0.000109	0.0036	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000109	0.00358	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000108	0.00356	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ANKRD1—dilated cardiomyopathy	0.000107	0.00353	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000102	0.00337	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000102	0.00335	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—TAZ—dilated cardiomyopathy	0.000101	0.00332	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	9.73e-05	0.0032	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—NR3C2—dilated cardiomyopathy	9.56e-05	0.00314	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	9.14e-05	0.00301	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—SDHA—dilated cardiomyopathy	9.12e-05	0.003	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.87e-05	0.00292	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TTN—dilated cardiomyopathy	8.48e-05	0.00279	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ANKRD1—dilated cardiomyopathy	8.45e-05	0.00278	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	8.34e-05	0.00274	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—GPX1—dilated cardiomyopathy	8.07e-05	0.00265	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	7.97e-05	0.00262	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—TAZ—dilated cardiomyopathy	7.94e-05	0.00261	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—CD36—dilated cardiomyopathy	7.86e-05	0.00259	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7.58e-05	0.00249	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	7.51e-05	0.00247	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	7.35e-05	0.00242	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.34e-05	0.00241	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—TNF—dilated cardiomyopathy	7.2e-05	0.00237	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—SDHA—dilated cardiomyopathy	7.18e-05	0.00236	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.14e-05	0.00235	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.14e-05	0.00235	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.13e-05	0.00234	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—ITGB1—dilated cardiomyopathy	7.11e-05	0.00234	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	7.1e-05	0.00234	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—AGT—dilated cardiomyopathy	7.08e-05	0.00233	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	7.06e-05	0.00232	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	6.89e-05	0.00227	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	6.85e-05	0.00225	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	6.68e-05	0.0022	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.64e-05	0.00218	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	6.39e-05	0.0021	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VCL—dilated cardiomyopathy	6.25e-05	0.00206	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—CD36—dilated cardiomyopathy	6.07e-05	0.00199	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	6.04e-05	0.00199	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—NPPA—dilated cardiomyopathy	6e-05	0.00197	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—RAC1—dilated cardiomyopathy	5.72e-05	0.00188	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	5.57e-05	0.00183	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.56e-05	0.00183	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	5.46e-05	0.0018	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	5.46e-05	0.0018	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.42e-05	0.00178	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	5.2e-05	0.00171	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	5.2e-05	0.00171	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	5.19e-05	0.00171	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	4.89e-05	0.00161	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.88e-05	0.0016	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	4.85e-05	0.0016	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	4.83e-05	0.00159	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	4.56e-05	0.0015	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—TAZ—dilated cardiomyopathy	4.54e-05	0.00149	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	4.43e-05	0.00146	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.38e-05	0.00144	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	4.33e-05	0.00142	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.27e-05	0.0014	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	4.13e-05	0.00136	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SDHA—dilated cardiomyopathy	4.1e-05	0.00135	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	4.07e-05	0.00134	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	3.98e-05	0.00131	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	3.95e-05	0.0013	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.9e-05	0.00128	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.84e-05	0.00126	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.79e-05	0.00125	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—RAF1—dilated cardiomyopathy	3.79e-05	0.00125	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	3.75e-05	0.00123	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	3.71e-05	0.00122	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	3.68e-05	0.00121	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.42e-05	0.00112	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	3.39e-05	0.00111	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	3.38e-05	0.00111	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	3.36e-05	0.0011	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	3.25e-05	0.00107	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	3.17e-05	0.00104	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	3.14e-05	0.00103	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	2.87e-05	0.000944	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—CD36—dilated cardiomyopathy	2.68e-05	0.00088	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—EGFR—dilated cardiomyopathy	2.6e-05	0.000855	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.53e-05	0.000834	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—RAC1—dilated cardiomyopathy	2.52e-05	0.00083	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.52e-05	0.000828	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.5e-05	0.000823	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GPX1—dilated cardiomyopathy	2.48e-05	0.000815	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—TNF—dilated cardiomyopathy	2.48e-05	0.000814	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.45e-05	0.000806	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.44e-05	0.000802	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CD36—dilated cardiomyopathy	2.41e-05	0.000793	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.25e-05	0.000739	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.21e-05	0.000726	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.19e-05	0.000722	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.19e-05	0.00072	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AGT—dilated cardiomyopathy	2.17e-05	0.000714	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.05e-05	0.000674	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.99e-05	0.000656	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.97e-05	0.000648	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GPX1—dilated cardiomyopathy	1.95e-05	0.000642	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CD36—dilated cardiomyopathy	1.9e-05	0.000625	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.8e-05	0.000591	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.75e-05	0.000576	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	1.74e-05	0.000571	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AGT—dilated cardiomyopathy	1.71e-05	0.000563	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.7e-05	0.000561	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CD36—dilated cardiomyopathy	1.69e-05	0.000556	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—RAF1—dilated cardiomyopathy	1.67e-05	0.00055	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	1.64e-05	0.00054	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	1.6e-05	0.000526	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.53e-05	0.000505	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AGT—dilated cardiomyopathy	1.52e-05	0.0005	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.45e-05	0.000476	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	1.44e-05	0.000473	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	1.12e-05	0.000369	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GPX1—dilated cardiomyopathy	1.11e-05	0.000367	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	1.09e-05	0.000359	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CD36—dilated cardiomyopathy	1.09e-05	0.000357	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	1e-05	0.000329	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	9.83e-06	0.000323	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AGT—dilated cardiomyopathy	9.77e-06	0.000321	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	9.74e-06	0.00032	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	9.2e-06	0.000303	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	9.12e-06	0.0003	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	8.96e-06	0.000295	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	8.88e-06	0.000292	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	8.77e-06	0.000289	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	8.07e-06	0.000265	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	8e-06	0.000263	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	7.8e-06	0.000256	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	7.59e-06	0.00025	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	6.84e-06	0.000225	CbGpPWpGaD
